The Contribution of genetic testing to the early detection and prevention of ischemic stroke
DOI:
https://doi.org/10.47611/jsrhs.v13i3.6947Keywords:
Ischemic Stroke, Prevent, GeneticsAbstract
Cerebrovascular accident, more commonly known as stroke, is defined by the National Health Institute as an incident that occurs when blood flow to the brain is blocked. The main symptom of stroke is a sudden numbness in the face, arm, or leg, especially on one side of the body. Other common symptoms include sudden confusion, trouble seeing, or dizziness. Depending on how the blood flow to the brain is limited, there are two main classifications of stroke: hemorrhagic and ischemic. Ischemic stroke, which makes up roughly 80% of all cases, occurs when blood flow to the brain is abruptly interrupted, resulting in a sudden loss of function. A study showed that heritability accounted for around 37.9% of all cases of ischemic stroke. Hence, the more urgent need to be able to detect, prevent and cure ischemic stroke, while adhering to strict moral and ethical principles. This literature review will explore how genetic testing and engineering can be used to detect, prevent and cure ischemic stroke. Through the analysis of genetic mutations linked to ischemic stroke, genetic engineering can identify the condition early and create personalised prevention approaches. Thus, genetic testing holds the potential to enhance the well-being of individuals who are vulnerable to or impacted by ischemic stroke.
Downloads
References or Bibliography
Donkor, E. S. (2018). Stroke in the21stCentury: A snapshot of the burden, epidemiology, and quality of life. Stroke Research and Treatment, 2018, 1–10. https://doi.org/10.1155/2018/3238165
Saini, V., Guada, L., & Yavagal, D. R. (2021). Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology, 97(20S), S6–S16. https://doi.org/10.1212/wnl.0000000000012781
Who emro. (n.d.). World Health Organization - Regional Office for the Eastern Mediterranean. Retrieved August 29, 2023, from https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html
CDC. (2022, December 7). Prevent stroke: What you can do. Centers for Disease Control and Prevention. https://www.cdc.gov/stroke/prevention.htm
Scarpa, A. (2019, October 18). What are the different Types of Stroke? Neofect Blog. https://us.blog.neofect.com/what-are-the-different-types-of-stroke/
- Debette, S., & Markus, H. S. (2022). Stroke genetics: Discovery, insight into mechanisms, and clinical perspectives. Circulation Research, 130(8), 1095–1111. https://doi.org/10.1161/circresaha.122.319950
Ahle, S. (2021, July 1). Demystifying the Lab: Cytogenetics. ASH Clinical News. https://www.ashclinicalnews.org/spotlight/demystifying-the-lab/demystifying-lab-cytogenetics
Whole genome sequencing. (2022, August 16). Cdc.gov. https://www.cdc.gov/pulsenet/pathogens/wgs.html
Whole-genome sequencing (WGS). (n.d.). Illumina.com. from https://www.illumina.com/techniques/sequencing/dna-sequencing/whole-genome-sequencing.html
Whole genome sequencing. (n.d.). Sequencing.com, from https://sequencing.com/education-center/whole-genome-sequencing
What are genome-wide association studies? (n.d.). Medlineplus.gov. from, https://medlineplus.gov/genetics/understanding/genomicresearch/gwastudies
Access to medicines: making market forces serve the poor. (n.d.). Who.int. from https://cdn.who.int/media/docs/default-source/essential-medicines/fair-price/chapter-medicines.pdf?sfvrsn=adcffc8f_4&download=true
Debette, S., & Markus, H. S. (2022). Stroke genetics: Discovery, insight into mechanisms, and clinical perspectives. Circulation Research, 130(8), 1095–1111. https://doi.org/10.1161/circresaha.122.319950
Zhao, W., Hu, X., Hao, J., Guo, L., Zhang, W., Liu, J., Jin, T., Gao, D., & Zhi, J. (2022). Effect of PITX2 genetic variants on the susceptibility to stroke in the Chinese Han population. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 98(105201), 105201. https://doi.org/10.1016/j.meegid.2021.105201
Hu, L., Ru, K., Zhang, L., Huang, Y., Zhu, X., Liu, H., Zetterberg, A., Cheng, T., & Miao, W. (2014). Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomarker Research, 2(1). https://doi.org/10.1186/2050-7771-2-3
Fluorescence in situ hybridization (FISH). (n.d.). Nature.com, from https://www.nature.com/scitable/topicpage/fluorescence-in-situ-hybridization-fish-327/
No title. (n.d.). Sigmaaldrich.com., from https://www.sigmaaldrich.com/ID/en/technical-documents/technical-article/genomics/pcr/polymerase-chain-reaction
Vlachakis, D., Tsaniras, S. C., Ioannidou, K., Papageorgiou, L., Baumann, M., & Kossida, S. (n.d.). A series of Notch3 mutations in CADASIL; insights from 3D molecular modelling and evolutionary analyses. Journal of Molecular Biochemistry, 3(3).
(N.d.-b). Thebiomedicalscientist.net. Retrieved August 30, 2023, from https://thebiomedicalscientist.net/sites/default/files/media/image/2019/biomed-ad_1.jpg
El Ezzi, A. A., Clawson, J. M., El-Saidi, M. A., Zaidan, W. R., Kovash, A., Orellana, J., Thornock, A., & Kuddus, R. H. (2020). Association of angiotensin I converting enzyme insertion/287 bp deletion polymorphisms and proliferative prostatic diseases among Lebanese men. Prostate Cancer, 2020, 1–6. https://doi.org/10.1155/2020/5959134
Saey, T. H. (2017, July 31). Explainer: How CRISPR works. Science News Explores. https://www.snexplores.org/article/explainer-how-crispr-works
(N.d.). Gstatic.com. from https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQ0bUxn_N2aGfmGqwU08eLCntjev1LctYe_D-BPEzR7RcLYX6m1w2fy7BscYWGZLkIDvVs&usqp=CAU
Scheller, E. L., & Krebsbach, P. H. (2009). Gene therapy: Design and prospects for craniofacial regeneration. Journal of Dental Research, 88(7), 585–596. https://doi.org/10.1177/0022034509337480
Sterling, J. (2023, February 21). Cell and gene therapy manufacturing costs limiting access. GEN - Genetic Engineering and Biotechnology News. https://www.genengnews.com/insights/cell-and-gene-therapy-manufacturing-costs-limiting-access/
Access to medicines: making market forces serve the poor. (n.d.). Who.int, from https://cdn.who.int/media/docs/default-source/essential-medicines/fair-price/chapter-medicines.pdf?sfvrsn=adcffc8f_4&download=true
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dong Min Huh

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.